Stages versus subsets: Invariant natural killer T cell lineage differentiation

Cytokine

Volumn 72, Issue 2, 2015, Pages 204-209

  Buechel, Heather M ^a   Stradner, Martin H ^b   D'Cruz, Louise M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Innate immunity; Lineage differentiation; T cell

Indexed keywords

CYTOKINE; E PROTEIN; INHIBITOR OF DIFFERENTIATION PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CELL INTERACTION; CELL LINEAGE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; CELL DIFFERENTIATION; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; METABOLISM;

CELL DIFFERENTIATION; CELL LINEAGE; CYTOKINES; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS;

EID: 84923792705     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.12.005     Document Type: Review

References (63)

1. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
2. Sag D., et al. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J Clin Invest 2014, 124(9):3725-3740.
3. Brigl M., et al. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003, 4(12):1230-1237.
4. Fox L., Hegde S., Gumperz J.E. Natural killer T cells: innate lymphocytes positioned as a bridge between acute and chronic inflammation?. Microbes Infect 2010, 12(14-15):1125-1133.
5. Mattner J., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434(7032):525-529.
6. Kronenberg M., Kinjo Y. Innate-like recognition of microbes by invariant natural killer T cells. Curr Opin Immunol 2009, 21(4):391-396.
7. Motohashi S., Nakayama T. Invariant natural killer T cell-based immunotherapy for cancer. Immunotherapy 2009, 1(1):73-82.
8. Van Kaer L., Parekh V.V., Wu L. Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens. Immunotherapy 2011, 3(1):59-75.
9. Wu L., Van Kaer L. Natural killer T cells and autoimmune disease. Curr Mol Med 2009, 9(1):4-14.
10. Brennan P.J., Brigl M., Brenner M.B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013, 13(2):101-117.
11. Constantinides M.G., Bendelac A. Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol 2013, 25(2):161-167.
12. + and respond preferentially under inflammatory conditions. J Immunol 2009, 183(3):2142-2149.
13. Lee Y.J., et al. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol 2013, 14(11):1146-1154.
14. Michel M.L., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007, 204(5):995-1001.
15. Watarai H., et al. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol 2012, 10(2):e1001255.
16. Townsend M.J., et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 2004, 20(4):477-494.
17. Matsuda J.L., et al. Homeostasis of Vα14i NKT cells. Nat Immunol 2002, 3(10):966-974.
18. Murre C. Helix-loop-helix proteins and lymphocyte development. Nat Immunol 2005, 6(11):1079-1086.
19. Monticelli L.A., et al. Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc Natl Acad Sci USA 2009, 106(46):19461-19466.
20. D'Cruz L.M., et al. E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation. J Immunol 2014, 192(5):2227-2236.
21. Hu T., et al. Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets. J Immunol 2013, 191(10):5065-5073.
22. Terashima A., et al. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 2008, 205(12):2727-2733.
23. Kim P.J., et al. GATA-3 regulates the development and function of invariant NKT cells. J Immunol 2006, 177(10):6650-6659.
24. Verykokakis M., et al. Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. J Immunol 2013, 191(12):5973-5983.
25. Schmitz R., et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012, 490(7418):116-120.
26. D'Cruz L.M., et al. An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nat Immunol 2010, 11(3):240-249.
27. Yang C.Y., et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat Immunol 2011, 12(12):1221-1229.
28. Seiler M.P., et al. Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat Immunol 2012, 13(3):264-271.
29. Coquet J.M., et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci USA 2008, 105(32):11287-11292.
30. Michel M.L., et al. Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci USA 2008, 105(50):19845-19850.
31. Rachitskaya A.V., et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008, 180(8):5167-5171.
32. Pichavant M., et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med 2008, 205(2):385-393.
33. Yoshiga Y., et al. Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis. Int J Mol Med 2008, 22(3):369-374.
34. Doisne J.M., et al. Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J Immunol 2011, 186(2):662-666.
35. Kinjo Y., et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 2011, 12(10):966-974.
36. Havenar-Daughton C., et al. Development and function of murine RORγt+ iNKT cells are under TGF-β signaling control. Blood 2012, 119(15):3486-3494.
37. Milpied P., et al. IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 2011, 118(11):2993-3002.
38. Glinka Y., Prud'homme G.J. Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 2008, 84(1):302-310.
39. Enders A., et al. ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells. J Immunol 2012, 189(11):5240-5249.
40. Engel I., et al. The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cells. Blood 2012, 120(23):4524-4532.
41. Chang P.P., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol 2012, 13(1):35-43.
42. King I.L., et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol 2012, 13(1):44-50.
43. Barral P., et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc Natl Acad Sci USA 2008, 105(24):8345-8350.
44. Leadbetter E.A., et al. NK T cells provide lipid antigen-specific cognate help for B cells. Proc Natl Acad Sci USA 2008, 105(24):8339-8344.
45. Tonti E., et al. NKT-cell help to B lymphocytes can occur independently of cognate interaction. Blood 2009, 113(2):370-376.
46. Lehuen A., Fazilleau N. Innate iNKT cell help to B cells: fast but does not last. Nat Immunol 2012, 13(1):11-13.
47. Bai L., et al. Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides. Proc Natl Acad Sci USA 2013, 110(40):16097-16102.
48. Parekh V.V., et al. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 2005, 115(9):2572-2583.
49. Sullivan B.A., Kronenberg M. Activation or anergy: NKT cells are stunned by α-galactosylceramide. J Clin Invest 2005, 115(9):2328-2329.
50. Cerundolo V., et al. Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 2009, 9(1):28-38.
51. Salio M., et al. Biology of CD1- and MR1-restricted T cells. Annu Rev Immunol 2014, 32:323-366.
52. Chiba A., et al. Rapid NKT cell responses are self-terminating during the course of microbial infection. J Immunol 2008, 181(4):2292-2302.
53. Masson F., et al. Id2 represses E2A-mediated activation of IL-10 expression in T cells. Blood 2014, 123(22):3420-3428.
54. Oh K., et al. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. J Immunol 2005, 174(4):2030-2036.
55. Ji Y., et al. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem 2012, 287(29):24378-24386.
56. Ji Y., et al. Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 2012, 287(17):13561-13571.
57. Lynch L., et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012, 37(3):574-587.
58. Huh J.Y., et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol 2013, 33(2):328-339.
59. Monteiro M., et al. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-β. J Immunol 2010, 185(4):2157-2163.
60. Moreira-Teixeira L., et al. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. J Immunol 2012, 188(2):624-631.
61. Engelmann P., et al. Characterization of human invariant natural killer T cells expressing FoxP3. Int Immunol 2011, 23(8):473-484.
62. Motohashi S., et al. A phase I-II study of α-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer. J Immunol 2009, 182(4):2492-2501.
63. Woltman A.M., et al. Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antivir Ther 2009, 14(6):809-818.